DR. REDDY'S LABORATORIES-ADR (RDY) Institutional Buying Activity
Institutional investors tracked by InsiderSet increased exposure to DR. REDDY'S LABORATORIES-ADR (RDY) during the quarter ended June 30, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.
Several hedge funds and long-term asset managers reported increases in RDY exposure during the latest reporting period based on SEC Form 13F filings.
Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward DR. REDDY'S LABORATORIES-ADR (RDY). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.
No data available.
Frequently asked questions about RDY activity
Which institutional owners are buying RDY?
Institutional owners buying RDY include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in RDY activity?
"Buy" means an investor increased their reported position in RDY compared to the prior reporting period. This reflects growing exposure to DR. REDDY'S LABORATORIES-ADR (RDY) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in RDY increasing?
Institutional interest in RDY can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.